28-Mar-2024
Analysts Are Bullish on Top Healthcare Stocks: Moderna (MRNA), Altimmune (ALT)
TipRanks (Thu, 28-Mar 8:00 AM ET)
ACCESSWIRE (Wed, 6-Mar 8:02 AM ET)
ACCESSWIRE (Tue, 5-Mar 8:02 AM ET)
Bausch Health Companies to Present at Cowen Annual Health Care Conference
ACCESSWIRE (Fri, 1-Mar 8:03 AM ET)
Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results
ACCESSWIRE (Thu, 22-Feb 7:05 AM ET)
Bausch Health Announces Board Refreshment
ACCESSWIRE (Thu, 1-Feb 4:13 PM ET)
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
ACCESSWIRE (Thu, 1-Feb 8:01 AM ET)
ACCESSWIRE (Tue, 30-Jan 8:03 AM ET)
ACCESSWIRE (Thu, 18-Jan 4:51 PM ET)
Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
ACCESSWIRE (Thu, 18-Jan 8:03 AM ET)
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Bausch Health Companies trades on the NYSE stock market under the symbol BHC.
As of March 28, 2024, BHC stock price climbed to $10.61 with 3,698,889 million shares trading.
BHC has a beta of 2.09, meaning it tends to be more sensitive to market movements. BHC has a correlation of 0.16 to the broad based SPY ETF.
BHC has a market cap of $3.88 billion. This is considered a Mid Cap stock.
Last quarter Bausch Health Companies reported $2 billion in Revenue and $1.15 earnings per share. This beat revenue expectation by $108 million and exceeded earnings estimates by $.13.
In the last 3 years, BHC stock traded as high as $34.50 and as low as $4.00.
The top ETF exchange traded funds that BHC belongs to (by Net Assets): ACTV, PPH, FDLS, DFIS, DFAX.
BHC has outperformed the market in the last year with a price return of +42.4% while the SPY ETF gained +33.6%. BHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +36.9% and +14.3%, respectively, while the SPY returned +10.1% and +1.7%, respectively.
BHC support price is $10.22 and resistance is $10.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BHC stock will trade within this expected range on the day.